logo
Select company
Select metric
$ -227.52MConsolidated Income
VS
Market
6
Sector
9
Industry
11
History
67
$ 4.64Close
$ 2.8 - $ 12.98 52-Week Range
Ticker Information

Ticker

ALMS

Company Name

ALUMIS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ALUMIS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ALMS - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -227.52M
3/31/2025$ -343.35M
12/31/2024$ -294.23M
12/31/2023$ -154.99M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ALUMIS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -154.99M.
  • Over the past 5 years, ALUMIS INC's average Cons. Inc. has been $ -255.02M.
  • The median Cons. Inc. for ALUMIS INC during this period was $ -260.88M
  • ALUMIS INC reached its highest Cons. Inc. over the past 5 years at $ -154.99M.
  • The lowest Cons. Inc. recorded by ALUMIS INC in the same timeframe $ -343.35M

ALUMIS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
BCYC : BICYCLE THERAPEUTICS PLC $ -242.36MCAPR : CAPRICOR THERAPEUTICS INC $ -69.98MVIR : VIR BIOTECHNOLOGY INC $ -550.23MFHTX : FOGHORN THERAPEUTICS INC $ -75.39MOABI : OMNIAB INC $ -63.52MTNXP : TONIX PHARMACEUTICALS HOLDING CORP $ -81.42MPRTA : PROTHENA CORP PUBLIC LTD CO $ -302.92MABUS : ARBUTUS BIOPHARMA CORP $ -54.25MZBIO : ZENAS BIOPHARMA INC $ -177.01MAUTL : AUTOLUS THERAPEUTICS PLC $ -227.78M

Similar metrics to Cons. Inc.:

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

ALMS - Consolidated Income, Last 5 years

$ -343.35M

Minimum

Mar 31, 2025

$ -154.99M

Maximum

Dec 31, 2023

$ -255.02M

Average

$ -260.88M

Median

Cons. Inc. Benchmark Analysis

 The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.01M with a standard deviation of $ 116.51M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.01M
median$ -2.1M
std$ 116.51M